Logo image of BRY.CA

BRI-CHEM CORP (BRY.CA) Stock Fundamental Analysis

Canada - TSX:BRY - CA10778T1057 - Common Stock

0.27 CAD
0 (0%)
Last: 10/16/2025, 7:00:00 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to BRY. BRY was compared to 12 industry peers in the Trading Companies & Distributors industry. BRY has a bad profitability rating. Also its financial health evaluation is rather negative. BRY does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BRY has reported negative net income.
In the past year BRY had a positive cash flow from operations.
In multiple years BRY reported negative net income over the last 5 years.
In multiple years BRY reported negative operating cash flow during the last 5 years.
BRY.CA Yearly Net Income VS EBIT VS OCF VS FCFBRY.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

1.2 Ratios

BRY's Return On Assets of -3.96% is on the low side compared to the rest of the industry. BRY is outperformed by 91.67% of its industry peers.
BRY has a worse Return On Equity (-10.89%) than 91.67% of its industry peers.
Industry RankSector Rank
ROA -3.96%
ROE -10.89%
ROIC N/A
ROA(3y)1.89%
ROA(5y)-2.15%
ROE(3y)7.6%
ROE(5y)-2.84%
ROIC(3y)N/A
ROIC(5y)N/A
BRY.CA Yearly ROA, ROE, ROICBRY.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

Looking at the Gross Margin, with a value of 16.70%, BRY is doing worse than 66.67% of the companies in the same industry.
BRY's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for BRY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.96%
GM growth 5Y-0.62%
BRY.CA Yearly Profit, Operating, Gross MarginsBRY.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

More info and screens

3

2. Health

2.1 Basic Checks

BRY does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BRY remains at a similar level compared to 1 year ago.
Compared to 5 years ago, BRY has more shares outstanding
The debt/assets ratio for BRY has been reduced compared to a year ago.
BRY.CA Yearly Shares OutstandingBRY.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
BRY.CA Yearly Total Debt VS Total AssetsBRY.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

BRY has an Altman-Z score of 1.46. This is a bad value and indicates that BRY is not financially healthy and even has some risk of bankruptcy.
BRY has a Altman-Z score of 1.46. This is amonst the worse of the industry: BRY underperforms 91.67% of its industry peers.
BRY has a debt to FCF ratio of 2.95. This is a good value and a sign of high solvency as BRY would need 2.95 years to pay back of all of its debts.
BRY has a Debt to FCF ratio of 2.95. This is amongst the best in the industry. BRY outperforms 91.67% of its industry peers.
A Debt/Equity ratio of 0.98 indicates that BRY is somewhat dependend on debt financing.
BRY has a worse Debt to Equity ratio (0.98) than 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF 2.95
Altman-Z 1.46
ROIC/WACCN/A
WACC8.75%
BRY.CA Yearly LT Debt VS Equity VS FCFBRY.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

BRY has a Current Ratio of 1.41. This is a normal value and indicates that BRY is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of BRY (1.41) is worse than 83.33% of its industry peers.
A Quick Ratio of 0.69 indicates that BRY may have some problems paying its short term obligations.
BRY's Quick ratio of 0.69 is on the low side compared to the rest of the industry. BRY is outperformed by 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 0.69
BRY.CA Yearly Current Assets VS Current LiabilitesBRY.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for BRY have decreased strongly by -16.35% in the last year.
Looking at the last year, BRY shows a very negative growth in Revenue. The Revenue has decreased by -11.74% in the last year.
The Revenue has been decreasing by -1.96% on average over the past years.
EPS 1Y (TTM)-16.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%131.89%
Revenue 1Y (TTM)-11.74%
Revenue growth 3Y11.21%
Revenue growth 5Y-1.96%
Sales Q2Q%7.49%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BRY.CA Yearly Revenue VS EstimatesBRY.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
BRY.CA Yearly EPS VS EstimatesBRY.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 0.1 0.2 0.3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

BRY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BRY.CA Price Earnings VS Forward Price EarningsBRY.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

BRY's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. BRY is more expensive than 83.33% of the companies in the same industry.
BRY's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BRY is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1.07
EV/EBITDA 20.43
BRY.CA Per share dataBRY.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BRY!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BRI-CHEM CORP

TSX:BRY (10/16/2025, 7:00:00 PM)

0.27

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)08-18 2025-08-18
Earnings (Next)11-12 2025-11-12
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners7.8%
Ins Owner ChangeN/A
Market Cap7.14M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.09
P/FCF 1.07
P/OCF 1.03
P/B 0.37
P/tB 0.37
EV/EBITDA 20.43
EPS(TTM)-0.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.25
FCFY93.64%
OCF(TTM)0.26
OCFY97.54%
SpS3.14
BVpS0.73
TBVpS0.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.96%
ROE -10.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.7%
FCFM 8.05%
ROA(3y)1.89%
ROA(5y)-2.15%
ROE(3y)7.6%
ROE(5y)-2.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.96%
GM growth 5Y-0.62%
F-Score2
Asset Turnover1.55
Health
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF 2.95
Debt/EBITDA 27.29
Cap/Depr 22.35%
Cap/Sales 0.33%
Interest Coverage N/A
Cash Conversion 994.9%
Profit Quality N/A
Current Ratio 1.41
Quick Ratio 0.69
Altman-Z 1.46
F-Score2
WACC8.75%
ROIC/WACCN/A
Cap/Depr(3y)93.13%
Cap/Depr(5y)56.73%
Cap/Sales(3y)1.06%
Cap/Sales(5y)0.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%131.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.74%
Revenue growth 3Y11.21%
Revenue growth 5Y-1.96%
Sales Q2Q%7.49%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-120.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y319.1%
FCF growth 3YN/A
FCF growth 5Y-15.31%
OCF growth 1Y928.61%
OCF growth 3YN/A
OCF growth 5Y-14.89%